Is BIO a buy or sell right now?

Innellis AI committee rates Bio-Rad Laboratories Watch with a composite score of 59/100.

Do analysts agree on BIO?

6 AI analysts evaluated Bio-Rad Laboratories, with 50 percent agreement on the overall direction.

NASDAQ · STOCK

Bio-Rad Laboratories

BIO Unknown Unknown Updated July 17, 2026

$304.08

AI Score

59/100

Market Cap

—

P/E Ratio

—

Beta

—

Is BIO Bullish or Bearish?

Mixed. Innellis AI committee rates Bio-Rad Laboratories (BIO) Watch with a composite score of 59/100 , based on 6 analysts with 50% agreement. Last updated July 17, 2026.

Executive Summary

6 analysts weighed in with 50% agreement on a bullish lean. Risk Analyst: Low leverage (debt-to-equity 0.16) -- balance sheet can absorb a shock. Overall recommendation: WATCH.

Price History (6M)

AI Investment Committee

Committee Consensus As of July 17, 2026

Overall Committee Score

59/100

Agreement

50%

Analysts

Conviction

Contested

Value Analyst neutral

50 / 100 · High confidence

Fair value -- neither a bargain nor obviously overpriced

+ Price-to-book of 1.1x is a discount to asset value

− P/E of 47.5 is expensive by classic value standards

Growth Analyst bearish

40 / 100 · Low confidence

Growth story is weak, decelerating, or inconsistent

Risk Analyst bullish

80 / 100 · Low confidence

Risk profile is manageable -- leverage, volatility, and event exposure all look contained

+ Low leverage (debt-to-equity 0.16) -- balance sheet can absorb a shock

Macro Analyst bullish

70 / 100 · Moderate confidence

Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor

+ Market regime is bullish (Bull market -- normal position sizing)

News Analyst bullish

60 / 100 · Low confidence

News flow and recent filings/analyst actions are net positive

− No news coverage in the last 14 days -- limited independent confirmation either way

Portfolio Manager neutral

55 / 100 · Moderate confidence

Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position

+ Portfolio position concentration is currently healthy

− 5 existing position pair(s) are highly correlated already

Open Full Terminal →

Technical Analysis

Technical analysis data not yet available for BIO.

Fundamental Analysis

Valuation

P/E Ratio —

P/B Ratio —

PEG Ratio —

Dividend Yield —

52W High —

52W Low —

Quality & Growth

ROE —

ROA —

Gross Margin —

Operating Margin —

Revenue Growth YoY —

Debt / Equity —

Key Risks

Risk data not available for BIO.

Get the Full BIO Analysis

Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A

Open in Terminal → Mobile